Tarsus Pharmaceuticals TARS
NASDAQ TARS
$75.19 -3.42 (-4.35%)
As of: Oct 1, 2026 · 2:43 PM EDT

Tarsus Pharmaceuticals (TARS) Interest Expenses (2022 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) recorded Interest Expenses of $2.16 million in Q2 2026, down 3.8% from $2.24 million a year earlier but up 1.3% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Interest Expenses (2022 - 2026) Analysis & Trends

On a TTM basis, Tarsus Pharmaceuticals' Interest Expenses came in at $8.77 million as of Jun 30, 2026, down 4.8% year-over-year; for FY2025, it was $8.94 million, up 13.8% from FY2024.

  • Annual Interest Expenses has increased for three straight years, with a three-year compound annual growth rate of 59.6% (FY2022 to FY2025).
  • Across earlier years, Interest Expenses came in at $7.85 million in FY2024 (+134.6%), $3.35 million in FY2023 (+52.2%) and $2.2 million in FY2022.
  • Quarterly Interest Expenses has ranged from $316,000 in Q1 2022 to $2.45 million in Q3 2024 over the past five years.
  • On a year-over-year basis, Interest Expenses has declined for four consecutive quarters, with growth averaging 53.9% over the last eight quarters.
  • Peak year-over-year performance for Interest Expenses in the last five years was growth of 185.0% in Q3 2024, against a decline of 7.2% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.13 million (Q1 2026), $2.21 million (Q4 2025) and $2.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn 2.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.16 Mn
Mar 31, 2026 2.13 Mn
Dec 31, 2025 2.21 Mn
Sep 30, 2025 2.27 Mn
Jun 30, 2025 2.24 Mn
Mar 31, 2025 2.21 Mn
Dec 31, 2024 2.31 Mn
Sep 30, 2024 2.45 Mn
Jun 30, 2024 2.11 Mn
Mar 31, 2024 983,000.00
Dec 31, 2023 989,000.00
Sep 30, 2023 858,000.00
Jun 30, 2023 815,000.00
Mar 31, 2023 684,000.00
Dec 31, 2022 692,000.00
Sep 30, 2022 633,000.00
Jun 30, 2022 544,000.00
Mar 31, 2022 316,000.00
API Access

Tarsus Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=TARS&period=max&api_key=YOUR_API_KEY